How GlaxoSmithKline missed red flags in China - LONDON (Reuters) - - TopicsExpress



          

How GlaxoSmithKline missed red flags in China - LONDON (Reuters) - With more compliance officers in China than in any country bar the United States, drugmaker GlaxoSmithKline Plc seemed well-positioned to do things right.Related StoriesG20 backs fundamental reform of corporate taxationThai navy denies allegation of Rohingya Muslim smugglingG20 talks focus on policy clarity, China offers olive branchUK picks JPMorgan to advise on bank share salesMursi supporters rally in... ow.ly/2ytCV5
Posted on: Fri, 19 Jul 2013 14:35:23 +0000

Trending Topics



Recently Viewed Topics




© 2015